Empirical Meropenem Versus Piperacillin/Tazobactam for Adult Patients With Sepsis

Clinical trial NCT06184659 · RECRUITING

Trial details

NCT number: NCT06184659
Sponsor: Scandinavian Critical Care Trials Group
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Sepsis Septic Shock

Start date: 2025-06-26
Primary completion: 2028-06-30
Enrollment: 5800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.